For more than 30 years, DuPont Nutrition & Health has been a global leader in the science, research, and production of probiotics, and the company has recently stressed that it offers the same expertise to customers in South Asia, with a key differentiator of quality manufacturing, customization, application and regulatory support and its science substantiation.

End consumers in South Asia will benefit from the well-researched strain portfolio of DuPont Danisco FloraFIT, customizable probiotics, and HOWARU premium probiotics that address digestive health, immune health, and women’s health.

“Strengthening our commitment to the probiotics industry, we have globally invested USD 100 million to increase our probiotics production, while we continue to maintain the high potency, stability and efficacy in our products,” said Parth Patel, business director, DuPont Nutrition & Health, South Asia.

“We have the capability to help our customers launch a probiotic solution in a matter of months in India.”

Anurag Jain, sales director, DuPont Nutrition & Health, South Asia, says: “Our HOWARU premium probiotics have been proven safe and efficacious in multiple gold standard, human clinical studies. They are scientifically formulated to provide condition-specific benefits backed by targeted clinical research.”

“Using our FloraFIT range, the end products meet the specific needs of your customers.”

With the wide range of DuPont Danisco premium probiotics, customers in South Asia will experience a wide range of stable, clinically documented probiotics, specialized sales and technical support, and expert legal and regulatory support finished product format options.

DuPont Nutrition & Health will be exhibiting at CPhI India 2016 from 21-23 November in Mumbai.